The Food and Drug Administration has just announced proposed labeling changes for many popular antidepressants used by adults and children alike. The labeling changes, however, apply only to use of these drugs by young adults (ages 18-24). The FDA is now concerned that recent studies have shown increased suicidal thoughts and behavior in young adults taking these medications and wants the labeling to provide additional warnings about this. These warnings are already required for children younger than 18 who are taking antidepressants. The critical period of time in many of these cases is the first several weeks after the medication is started.
For parents, it is particularly important that you closely observe your children during this period. Any suicidal tendencies must be addressed by the physician promptly. While antidepressants can be very helpful in some cases, they can prove deadly in others. Some of the medications proposed by the FDA for labeling changes include well-known drugs such as: Elavil, Effexor, Lexapro, Pamelor, Paxil, Prozac, Seroquel, Wellbutrin, Zoloft and Zyban.
If your child has injured himself in an attempted suicide or actually committed suicide while taking one of these antidepressants, you may want to speak with an experienced medical malpractice attorney.